← Open Payments lookup

LATRICIA LACY-JUSTE: Open Payments

NPI 1073975090 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$888 in 43 payments from 11 companies in 2025. Trend: 2023 $262 · 2024 $419 · 2025 $888

Food & beverage: $888
CompanyPaymentsAmount
ABBVIE INC.10$215
Otsuka America Pharmaceutical, Inc.12$189
Janssen Pharmaceuticals, Inc1$95
Neurocrine BioSciences, Inc.4$85
Takeda Pharmaceuticals U.S.A., Inc.3$71
E.R. Squibb & Sons, L.L.C.3$62
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$62
Lundbeck LLC3$48
Almatica Pharma LLC2$30
Alkermes, Inc.1$17

Products named: VRAYLAR, REXULTI, SPRAVATO, INGREZZA, TRINTELLIX, COBENFY, CAPLYTA, ABILIFY ASIMTUFII.

Industry payments across NV — which companies pay providers there.